Movers and shakers Australian Life Scientist Speciality pharmaceutical company Hatchtech has appointed Dr Ross McDonald as its CEO, as it prepares to commercialise head lice treatment DeOvo. McDonald is currently a non-executive director on the Hatchtech board. He has 24 years' experience in the ... |
Ross Macdonald to lead Australian pharma company Hatchtech PMLiVE Australian pharma firm Hatchtech has appointed Dr Ross Macdonald as its new CEO as the company prepares to initiate phase III trials for novel head lice treatment product DeOvo. Dr Macdonald is currently a non-executive director of Hatchtech's board, ... Hatchtech appoints new CEO and completes financing round |
No Head Lice is a New Year's Resolution to Keep Sacramento Bee "A head start on 2012 should not include head lice," says Maria Botham, CEO of Hair Fairies. "Kids going back to school after crowded holiday travels and sleep-overs can be unaware they are carriers for lice. It's not unusual for parents to be ... |
No Head Lice is a New Year's Resolution to Keep MarketWatch (press release) "A head start on 2012 should not include head lice," says Maria Botham, CEO of Hair Fairies. "Kids going back to school after crowded holiday travels and sleep-overs can be unaware they are carriers for lice. It's not unusual for parents to be ... |
It's peak season for head lice in schools News1130 Head lice is a likely possibility during the first month in the classroom. The kids are all clumped together sharing their cubby spaces and sharing the little critters with their classmates, says Dawn Mucci, CEO of LiceSquad Canada. ... |